Replies to post #19 on Spark Therapeutics, Inc. (ONCE)

[crudeoil24]

This has the potential to be $500.+ by end of year. Float appears to be 1M
shares. Company controls shares. First ever FDA gene therapy approval product in a matter of a few months. DAT'S WHAT I'M TALKIN 'BOUT.